The Leading Edge Research Grant Program from the Lung Cancer Research Foundation (LCRF) supports lung cancer researchers worldwide. The research areas supported by the program include:
- Lung cancer biology
- Risk reduction and screening for early detection
- Identification of new biomarkers
- Development of more effective and less toxic therapies including but not limited to targeted and immune-therapies
- Genetic and gene-environment interactions
- Interactions and contributions of multiple factors (e.g. smoking, genetics, environment, societal factors) to disparities in lung cancer outcomes
- Mechanisms of sensitivity and resistance to lung cancer therapies
- Bioengineering approaches to understanding and/or treating lung cancer (i.e., theranostics, biomaterials, nanotechnology, controlled-drug release, and gene therapy)
- Supportive measures for people with lung cancer and their families
- Identification of metabolic vulnerabilities in lung cancer
Applications are open to post-doctoral researchers, clinical fellows, or early- and mid-career investigators with less than 10 years’ experience since their initial faculty appointment. Applicants may be based at universities and research institutions anywhere in the world. The grant provides 150,000 USD/year over 2 years and does not cover indirect costs.
Letters of intent are due on March 4, 2024 and invited full applications are due on June 10, 2024.
June 10, 2024